ACTH levels in maternal, fetal and neonatal plasma after short-term prenatal dexamethasone therapy. 1977

A Kauppila, and S Similä, and O Ylikorkala, and M Koivisto, and P Mäkelä, and J Haapalahti

The effect of prenatal dexamethasone therapy (12, 8 and 4 mg doses given intramuscularly on three consecutive days) on ACTH levels in maternal plasma (n=33), mixed umbilical cord plasma (n=31) and plasma from the newborn (n=29) was studied, and the results were compared with those obtained in 56 healthy parturients and 50 of their newborn. Maternal ACTH after delivery was significantly lower in the mothers treated with dexamethasone than in the control group. Cord ACTH values were similar in the two groups. ACTH levels fell during the early neonatal period, but only at 12 to 24 hours were the ACTH levels significantly lower in the dexamethasone group than in the controls. Gestational age, birth weight and the interval between the dexamethasone therapy and delivery had no significant effect on cord ACTH levels. Short-term prenatal dexamethasone therapy seemed to have very little effect on ACTH secretion in the mother, in the fetus and in the newborn.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D005260 Female Females
D005312 Fetal Blood Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery. Cord Blood,Umbilical Cord Blood,Blood, Cord,Blood, Fetal,Blood, Umbilical Cord,Bloods, Cord,Bloods, Fetal,Bloods, Umbilical Cord,Cord Blood, Umbilical,Cord Bloods,Cord Bloods, Umbilical,Fetal Bloods,Umbilical Cord Bloods
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000324 Adrenocorticotropic Hormone An anterior pituitary hormone that stimulates the ADRENAL CORTEX and its production of CORTICOSTEROIDS. ACTH is a 39-amino acid polypeptide of which the N-terminal 24-amino acid segment is identical in all species and contains the adrenocorticotrophic activity. Upon further tissue-specific processing, ACTH can yield ALPHA-MSH and corticotrophin-like intermediate lobe peptide (CLIP). ACTH,Adrenocorticotropin,Corticotropin,1-39 ACTH,ACTH (1-39),Adrenocorticotrophic Hormone,Corticotrophin,Corticotrophin (1-39),Corticotropin (1-39),Hormone, Adrenocorticotrophic,Hormone, Adrenocorticotropic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Kauppila, and S Similä, and O Ylikorkala, and M Koivisto, and P Mäkelä, and J Haapalahti
October 1982, The Journal of pediatrics,
A Kauppila, and S Similä, and O Ylikorkala, and M Koivisto, and P Mäkelä, and J Haapalahti
October 2004, Trends in endocrinology and metabolism: TEM,
A Kauppila, and S Similä, and O Ylikorkala, and M Koivisto, and P Mäkelä, and J Haapalahti
January 1981, Acta obstetricia et gynecologica Scandinavica,
A Kauppila, and S Similä, and O Ylikorkala, and M Koivisto, and P Mäkelä, and J Haapalahti
March 1972, The Journal of clinical endocrinology and metabolism,
A Kauppila, and S Similä, and O Ylikorkala, and M Koivisto, and P Mäkelä, and J Haapalahti
January 1990, Life sciences,
A Kauppila, and S Similä, and O Ylikorkala, and M Koivisto, and P Mäkelä, and J Haapalahti
January 1987, Archives of gynecology and obstetrics,
A Kauppila, and S Similä, and O Ylikorkala, and M Koivisto, and P Mäkelä, and J Haapalahti
July 1992, The Journal of clinical endocrinology and metabolism,
A Kauppila, and S Similä, and O Ylikorkala, and M Koivisto, and P Mäkelä, and J Haapalahti
March 1991, Nihon Sanka Fujinka Gakkai zasshi,
A Kauppila, and S Similä, and O Ylikorkala, and M Koivisto, and P Mäkelä, and J Haapalahti
January 1978, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
A Kauppila, and S Similä, and O Ylikorkala, and M Koivisto, and P Mäkelä, and J Haapalahti
January 2009, Clinical and experimental obstetrics & gynecology,
Copied contents to your clipboard!